Drobyski, W R <br/><br/>
T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation.  [electronic resource] 

 -  Blood  Jul 1999 
 - 434-41 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Biomarkers, Tumor--blood<br/>Bone Marrow Transplantation--adverse effects<br/>Cyclosporine--therapeutic use<br/>Female<br/>Follow-Up Studies<br/>Fusion Proteins, bcr-abl--blood<br/>Gastrointestinal Hemorrhage--etiology<br/>Graft Enhancement, Immunologic<br/>Graft vs Host Disease--mortality<br/>Graft vs Tumor Effect<br/>HLA Antigens--immunology<br/>Histocompatibility<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Incidence<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--mortality<br/>Leukemia, Myeloid, Chronic-Phase--mortality<br/>Leukocyte Transfusion<br/>Life Tables<br/>Lymphocyte Depletion<br/>Male<br/>Middle Aged<br/>Neoplasm, Residual<br/>Nuclear Family<br/>Polymerase Chain Reaction<br/>Salvage Therapy<br/>Survival Analysis<br/>T-Lymphocytes<br/>Tissue Donors<br/>Transplantation Conditioning<br/>Transplantation, Homologous<br/>Treatment Outcome